Kotarosumitomo Nakayama

Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis

Yoshihiro Kamada, Maaya Akita, Yuri Takeda et al. · PLoS ONE · 2013 · 71 citations · Full text

Mutation of GDP-Mannose-4,6-Dehydratase in Colorectal Cancer Metastasis

Kotarosumitomo Nakayama, Kenta Moriwaki, Taku Imai et al. · PLoS ONE · 2013 · 47 citations · Full text

Tumor Biology, Gmds Mutation, Medicine +12

Core fucose is essential glycosylation for CD14-dependent Toll-like receptor 4 and Toll-like receptor 2 signalling in macrophages

Kotarosumitomo Nakayama, Kana Wakamatsu, Hironobu Fujii et al. · The Journal of Biochemistry · 2018 · 37 citations

Innate Immune System, Immunology, Immune Regulation +21

Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method)

Mika Hosokawa, Hirokazu Kashiwagi, Kotarosumitomo Nakayama et al. · Transfusion · 2018 · 31 citations

Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis

Koichi Morishita, Nami Ito, Sayaka Koda et al. · Clinica Chimica Acta · 2018 · 28 citations

Pancreatic Cancer Diagnosis, Pancreatic Cancer, Medicine +8